Sanofi, AbbVie and Genmab Celebrate Mid-Phase Trial Wins
Felicia Rodriguez
April 14, 2022
Via: https://www.biospace.com/article/abbie-genmab-sanofi-score-respective-mid-phase-trial-wins/ Published: Apr 14, 2022 By Vanessa Doctor, MS AbbVie and Genmab announced positive topline results from their Phase I/II trial on an investigational antibody for relapsed and refractory large B-cell lymphoma. Initial results from the first cohort of the Epcore NHL-1 study covered 157 patients who were given